Cat. No.: X24-08-YM018
Topoisomerase inhibitor, Irinotecan, Purity ≥98%
Synonym: 97682-44-5; Camptosar; CPT-11; [(19S)-10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate
- MDL: MFCD00866307
- CAS Number: 97682-44-5
- Compound CID: 60838
Product Size
100 mg; 200 mg; 500 mg; 1000 mg
Properties
Description
Irinotecan, soluble in DMSO and insoluble in water and ethanol, is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting topoisomerase.
Molecular Formula
C33H38N4O6
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 6 mg/mL (10.23 mM); Water: insoluble; Ethanol: insoluble; In vivo: 30% propylene glycol, 5% Tween 80, 65% D5W, 28 mg/mL
Applications
Irinotecan is a DNA damage inhibitor that plays a key role in DNA damage and cancer cell death.
Related Products
- Topoisomerase inhibitor, ABT-492, Purity ≥98%
- Topoisomerase inhibitor, Amonafide, Purity ≥98%
- Topoisomerase inhibitor, Camptothecin, Purity ≥98%
- Topoisomerase inhibitor, Gatifloxacin, Purity ≥98%
- Topoisomerase inhibitor, Idarubicin HCl, Purity ≥98%
- Topoisomerase inhibitor, Irinotecan HCl trihydrate, Purity ≥98%